Cutaneous Leishmaniasis with Mucosal Involvement
PDF
Cite
Share
Request
Case Report
P: 227-229
September 2021

Cutaneous Leishmaniasis with Mucosal Involvement

Turkiye Parazitol Derg 2021;45(3):227-229
1. Hatay Mustafa Kemal Üniversitesi Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, Hatay, Türkiye
2. Hatay Mustafa Kemal Üniversitesi Tıp Fakültesi, Parazitoloji Anabilim Dalı, Hatay, Türkiye
3. Hatay Mustafa Kemal Üniversitesi Tıp Fakültesi, Deri ve Zührevi Hastalıkları Anabilim Dalı, Hatay, Türkiye
No information available.
No information available
Received Date: 07.04.2021
Accepted Date: 04.06.2021
Publish Date: 04.08.2021
PDF
Cite
Share
Request

ABSTRACT

Leishmaniasis is a protozoan parasitic disease transmitted to humans by infected female sand flies. Turkey has received more than three million immigrants from Syria because of the civil war and political instability. This study reported cases of two patients, who were from Syria and lived in Hatay, with cutaneous leishmaniasis and mucosal involvement. Two patients presented to the infectious diseases clinic with a complaint of facial lesions and were subsequently referred to the parasitology department laboratory. Smears were prepared from the lesions, stained with Giemsa and examined under a microscope. Moreover, aspirates taken from the patients’ lesions were inoculated into the modified Novy-MacNeal-Nicolle medium. The diagnosis was made when amastigotes were detected in both smears. Proliferation of promastigotes was observed in one of the clinical specimens inoculated on the medium. By PZR-RFLP, Leishmania tropica were detected in the isolate. Both patients were treated with amphotericin B. One patient was treated again with a pentavalent antimony compound because of the recurrence of the lesion.

Keywords: Leishmaniasis, Leishmania tropica, treatment

References

1
Alan J. Magill. Leishmania Species: Visceral (Kala Azar), Cutaneous, and Mucosal leishmaniasis. In: John E. Bennett, Raphael Dolin, Martin J. Blaser, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Philadelphia: Elsevıer Saunders; 2015. p. 3091-107.
2
Leishmaniasis fact sheet. Geneva: World Health Organization; 2020 (https://www.who.int/news-room/fact-sheets/detail/leishmaniasis, accessed May 2020).
3
World Health Organization. Weekly epidemiological record. Global leishmaniasis surveillance, 2017-2018, and first report on 5 additional indicators 2020;95:265-280.
4
Toz SO, Nasereddin A, Ozbel Y, Ertabaklar H, Culha G, Sevil N, et al. Leishmaniasis in Turkey: molecular characterization of Leishmania from human and canine clinical samples. Trop Med Int Health 2009; 14: 1401-6. 
5
Çulha G, Kaya T, Gülbol Duran G, Urhan Küçük M, Doğramacı AÇ, Tiyekli Çelik D. Mikroskop İncelemesi Negatif Olan Şüpheli Kronik Kutanöz Leishmania Olgularının Polimeraz Zincir Reaksiyonu Yöntemi ile Araştırılması [Investigation of Polymerase Chain Reaction Method in Patients with Suspected Chronic Cutaneous Leishmania of Negative Microscopy]. Mikrobiyol Bul 2019; 53: 408-18. 
6
Ozbel Y, Turgay N, Ozensoy S, Ozbilgin A, Alkan MZ, Ozcel MA, et al. Epidemiology, diagnosis and control of leishmaniasis in the Mediterranean region. Ann Trop Med Parasitol 1995; 89(Suppl 1): 89-93.
7
Özbilgin A, Çulha G, Güray MZ, Zeyrek FY, Akyar I, Töz S, et al. Türkiye’de Kutanöz Leyşmanyazis Hastalarından Elde Edilen Leishmania İzolatlarındaki Farklılıklar ve Bunların Fare Modeline Klinik Yansıması [Diversity of Leishmania Strains Isolated from Cutaneous Leishmaniasis Patients in Turkey and its Reflection to Clinics in Mice Model]. Mikrobiyol Bul 2020; 54: 429-443.
8
Özbilgin A, Töz S, Harman M, Günaştı Topal S, Uzun S, et al. The current clinical and geographical situation of cutaneous leishmaniasis based on species identification in Turkey. Acta Trop 2019; 190: 59-67. 
9
Osorio LE, Castillo CM, Ochoa MT. Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics. Am J Trop Med Hyg 1998; 59: 49-52. 
10
World Health Organization. Weekly epidemiological record. Surveillance of leishmaniasis in the WHO European Region, 2016. 2018; 93: 521-40.
11
Ekiz O, Kahraman ŞŞ, Şen BB, Serarslan G, Rifaioğlu EN, Culha G, et al. Mucocutaneous leishmaniasis with marked facial disfigurement. Indian J Dermatol Venereol Leprol 2017; 83: 91-3. 
12
Blum J, Desjeux P, Schwartz E, Beck B, Hatz C. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 2004; 53: 158-66.
2024 ©️ Galenos Publishing House